Lilly forecasts weak sales of weight-loss drug, shares slump
Eli Lilly's stock dropped 8% after forecasting fourth-quarter sales of its weight-loss drug Zepbound below Wall Street estimates, marking the sec…
More →
Eli Lilly study shows Alzheimer's drug slows disease
An experimental Alzheimer's drug from Eli Lilly has shown to significantly slow the progression from the brain-wasting disease. Researchers said …
More →
Lilly drug slows Alzheimer's progression by 35% in trial
An experimental Alzheimer's drug developed by Eli Lilly slowed cognitive decline by 35% in a closely watched late-stage trial, the company said, …
More →
Eli Lilly cuts insulin prices by 70% in the U.S.
Eli Lilly said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quart…
More →
U.S., Lilly strike deal for potential COVID-19 drug
The U.S. government will pay as much as $1.19 billion to Eli Lilly to secure nearly 1 million doses of its experimental COVID-19 antibody treatment.
More →
Eli Lilly pauses trial of antibody drug over safety concern
U.S. drugmaker Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Donal…
More →
Suscribirse a:
Entradas (Atom)
Follow us on social networks!